U.S. Biotech Ariad Builds European Presence For Imminent Iclusig Launches
This article was originally published in The Pink Sheet Daily
Executive Summary
A new Swiss HQ for its European business and country-focused medical marketing teams are part of U.S.-based Ariad's solo push into the region, to be followed by development of new indications and new cancer-targeted therapies.